Intranasal Drug Delivery: How, Why and What for?
Open accessThe DOI matches its Crossref record; 174 of the 175 references it cites were found in a registry or an index.
Abstract
Over the last decade the interest in intranasal delivery as a non-invasive route for drug administration has been exponentially increased. Since the nasal mucosa offers numerous benefits as a target issue for drug delivery, a wide variety of therapeutic compounds may be administered intranasally for topic, systemic and central nervous system action. The present paper reviews the relevant aspects of nasal anatomy, physiology and histology, and refers to the biological, physicochemical and pharmaceutical factors that must be considered during the process of discovery and development of nasal drugs as well as in their incorporation in appropriate nasal pharmaceutical formulations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It is non-invasive, painless, non-stressful, and relatively easy to perform without requiring a medical specialist [246,247,248].”
From Alzheimer's Disease: Treatment Strategies and Their Limitations. (2022) · cites this paper as [248]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Introduction and General Overview of Cyclodextrin Chemistry
Szejtli, J. (1998) · Chemical Reviews · doi:10.1021/cr970022c · Cited by 5,016
Chitosan Chemistry and Pharmaceutical Perspectives
Kumar, M. N. V. R., Muzzarelli, R. A. A., Muzzarelli, C., Sashiwa, H., & Domb, A. J. (2004) · Chemical Reviews · doi:10.1021/cr030441b · Cited by 2,938
Encyclopedia of Pharmaceutical Technology
Swarbrick, J. (2013) · CRC Press eBooks · doi:10.1201/b19309 · Cited by 1,794
Encyclopedia of pharmaceutical technology
(2003) · Choice Reviews Online · doi:10.5860/choice.40-6157 · Cited by 1,743
Abramson, M. H. (1996) · The Endocrinologist · doi:10.1097/00019616-199603000-00014 · Cited by 1,400
The Lung: Scientific Foundations
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-503_2 · Cited by 1,190
Nasal drug delivery—possibilities, problems and solutions
Illum, L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00363-2 · Cited by 1,102
Thorne, R. G., Pronk, G. J., Padmanabhan, V., & Frey, W. H. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.029 · Cited by 958
Transport of drugs from the nasal cavity to the central nervous system
Illum, L. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00087-7 · Cited by 907
Hanson, L. R., & Frey, W. H. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s3-s5 · Cited by 697
Research works printed but not linked: 5
- [27]27. Stevens A., Lowe J., Human histology, Mosby, Philadelphia, USA, 1997.
- [35]35. Dae-Duk Ki, Drug Absorption Studies: In situ, In vitro and In silico models, chapter 9, Springer, USA, 2007.
- [56]56. Varshosaz J, Sadrai H, Heidari A. Nasal delivery of insulin using bioadhesive chitosan gels. Drug Deliv, 2006; 13:31-38.
- [72]72. Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF. Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus in infants and young children. J Infect Dis, 2004; 190:2096-2103.
- [113]113. Hussain A.A., Bawarshi-Nassar R., Huang C.H., Transnasal Systemic Medications. Elsevier, Amsterdam, 1985. 123.
Cited by
Items 601–661 of 661
(2011) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e32834344aa
Jacobsen, N. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9325
Vu, T. H. N., Morozkina, S. N., Snetkov, P., & Uspenskaya, M. V. (2023) · Advanced clinical pharmacy - research, development and practical applications/Advanced clinical pharmacy - research, development and practical applications · doi:10.1007/978-3-031-26908-0_16
Desarrollo y evaluación clínica de una formulación intranasal de butorfanol para uso en equinos
Velloso, M. I. (2023) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/152394
Alcantara, K. P., Rojsitthisak, P., Vajragupta, O., & Rojsitthisak, P. (2021) · Chula Digiverse · doi:10.58837/chula.the.2021.305 · Cited by 1
(2023) · International Research Journal of Modernization in Engineering Technology and Science · doi:10.56726/irjmets47523
Alsamarrai, A. M., El-Zaafarany, G. M., & Kamel, A. O. (2023) · Archives of Pharmaceutical Sciences Ain Shams University · doi:10.21608/aps.2023.253006.1151
Ezzi, S., Salamatullah, H. K., Alzahrani, D., Alshrif, A., Faidah, D. E., Baljoon, J. M., Hakami, A. Y., & Babkair, K. A. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4682354
Different administration routes for nanovectors in cancer immunotherapy
Vaez, A., Amani, A. M., Salehi, M., Zarei‐Behjani, Z., Rezvani, A., Dourtaj, H., Hooshmand-Ardakani, A., & Arabpour, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-18770-4.00013-5
Cabellon, S. X. (2024) · Digital Repository Service (Northeastern University) · doi:10.17760/d20659800
Nasal Vaccine: A Special Prominence on SARS-CoV-2
Chattopadhyay, S., Nag, M., Bora, R., Maity, S. C., Mishra, D., Biswas, S., Bhattacharyya, S. P., Pal, R., & Alam, F. (2024) · Coronaviruses · doi:10.2174/0126667975293193240826093456
Peptides, Proteins and Antibodies
Gennaro, S. I. D., & Lalatsa, A. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_19
Recent Advancements in Nasal Drug Delivery Devices
Desai, Patil, P. D., Jadhav, S. A., & Koparde, A. A. (2024) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.14.4.66 · Cited by 1
Wang, P., Li, Y., Xu, B., Zhang, P., Cui, C., & Li, X. (2025) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.1507
Martin, G., & Lansley, A. B. (2013) · University of Brighton Repository (University of Brighton)
Intranasal drug delivery: reality and prospects
Lavrenova, G. V., & Oganyan, K. A. (2025) · Russian Rhinology · doi:10.17116/rosrino202533021143
A Review of the Studies Conducted on the Quality of Professional Life of Working Nurses
Far, M. M., Bandani, D. A., Namnik, N., & Makyani, Z. (2023) · Clinical Cancer Investigation Journal · doi:10.51847/wnkffz6vvr
“GEPANTS” CGPR ANTAGONIST – A NEW CLINICAL APPROACH TO TREAT MIGRAINE AND NEUROPEPTIDES
Sharma, M., & ARORA, K. (2025) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2025v18i7.54791
Herbal Formulations for Transmucosal Drug Delivery
Banerjee, D., Saharan, V. A., & Singh, A. (2025) · Wiley eBooks · doi:10.1002/9781119769484.ch9
Nose-to-Brain Drug Delivery: An Update on Clinical Challenges and Progress
Gangane, P. S., Raulkar, N., Wagh, N., Rabade, V., & Sawarkar, H. S. (2025) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.20253959
Nasal In Situ Hydrogels: A Boon For Anti-Emetic Drug Delivery
Boraste, S. V., & Patil, S. K. (2025) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2025053412
Alternative/Noninvasive routes of administration of insulin
Sonia, T. A., & Sharma, C. P. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-30272-5.00009-3
Ujita, H., Higuchi, H., Nishioka, Y., Miyake, S., Sato, R., & Miyawaki, T. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17111446
Elucidating bioadhesive processes in nasal drug delivery systems
Armstrong, M. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University) · doi:10.48730/6nbf-yx94
Alternative strategies to improve intranasal and nose-to-brain drug delivery
Corazza, E. (2024) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.48676/unibo/amsdottorato/11633
Effects of excipients in nasal powder formulations for systemic drug delivery
Trenkel, M. (2023) · MACAU: Open Access Repository of Kiel University (University Library Kiel)
Intranasaalinen lääkkeenanto : kirjallisuuskatsaus
Kuvaja, V. (2024) · UTUPub (University of Turku)
The Potential Use of Degradable Starch Microspheres as a Carrier for Nasal Drug Administration
Unal, R. (2023) · Lund University Publications Student Papers (Lund University)
Tiainen, S. (2025) · UTUPub (University of Turku)
Current Advances in Drug Development, Design, and Strategies for Brain Tumors
Waghulde, S., Pawar, D., & Vaidhun, B. H. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898811716125010004
Farmácia Avenida Mais, Porto e Serviços Farmacêuticos do Hospital Lusíadas, Porto
Filipe, E. C. (2023) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/5km0-kt31
Pharmacokinetics of intranasal levetiracetam in healthy dogs: a feasible route of administration
Królak, E., Thungrat, K., Gross, A. L., Gerken, K. K., Kuo, K. W., & Jukier, T. (2025) · American Journal of Veterinary Research · doi:10.2460/ajvr.25.10.0366
Enhancing nasal retention: using the mucosal blanket to structure spraysPreprint
Wang, J. T.-W., Tsang, C. W., Yip, N. C., & Hsu, S.-C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.12.698967
REVIEW OF PRADHMAN NASYA: CLASSICAL FOUNDATION AND MODERN SCIENTIFIC PERSPECTIVE
Nawani, P., Pandey, S., Panwar, B., & Bhatkoti, M. (2025) · International Ayurvedic Medical Journal · doi:10.46607/iamj0713112025
Hamad, S. A., Othman, Z. S., Salih, S. H. H., & Abdullah, T. M. (2026) · RSC Pharmaceutics · doi:10.1039/d5pm00261c
NSAIDsを含有する脳標的経鼻投与製剤の開発に向けたイオン液体の適用に関する研究
Tanigawa, H. (2024) · Institutional Repositories DataBase (IRDB) · doi:10.15006/0002002256
Supercritical impregnation for the elaboration of controlled drug delivery systems
Bouledjouidja, A. (2016) · theses.fr (ABES) · doi:10.70675/0971d29fz37b2z4dc4zb0acz66f8e91f2911 · Cited by 2
Kakhi, Z. (2014) · theses.fr (ABES) · doi:10.70675/f378dc91zf860z4bfcz9c1fz2011d41d5137
Traitement d’urgence du paludisme sévère chez l’enfant par application intranasale d’artésunate
Kouakou, Y. I. (2022) · theses.fr (ABES) · doi:10.70675/47d51b08zcb03z40f8za603z0a70fb64f6cb
Jaghatha, T., Edward, J. O. J., Arumugam, S., Pazhani, P., & Dharmian, J. P. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-10573-3
Al-hejaili, O. D., El‐Sawy, H. S., Teaima, M. H. M., El-Nabarawi, M. A., & El‐Say, K. M. (2026) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2026v18i4.58534 · Cited by 1
Ahmad, N., Rashid, M., Ullah, Z., Akhtar, N., Ahmad, M. M., Athar, M. T., Khan, S., Khan, M. F., & Ahmad, S. (2026) · Polymer Bulletin · doi:10.1007/s00289-026-06428-z
Ramzy, L., Elmowafy, E. M., Osman, R., & Awad, G. A. S. (2026) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2026.108450
Nose-to-Brain Delivery of Biologicals
Torres, J., Correia, A. C., & Silva, A. C. (2025) · Springer handbooks · doi:10.1007/978-3-032-01636-2_8
Biomaterials for intranasal administration
Garg, S., Vikal, A., Singhai, D. N., Sharma, R., Kumar, A., Singh, C., Singh, N., Patel, P., & Kurmi, B. D. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-31604-3.00013-6
Saylor, E. M., Kouba, A. J., Boudreau, M. R., Songsasen, N., & Kouba, C. K. (2026) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpa.2026.112034
МОДЕЛИРОВАНИE ИНГАЛЯЦИОННОГО ВОЗДЕЙСТВИЯ В ТОКСИКОЛОГИЧЕСКОМ ЭКСПЕРИМЕНТЕ
Vasilkevich, V. M., Evtereva, A. A., & Bogdanov, R. V. (2026) · DOAJ (DOAJ: Directory of Open Access Journals) · doi:10.60797/bmed.2026.9.5
Nose-to-Eye Delivery: The Potential of Intranasal Administration in Ophthalmology
Adezio, M. L., Iannetta, D., Manni, G., Visioli, G., Roberti, G., & Alisi, L. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15135029
Nanocarrier-Based Delivery of Biological Molecules for Neurodegenerative Disease Treatment
Takahashi, M. M., Scharf, P. R. D. S., & Farsky, S. H. P. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00054
Advanced Materials for Biologics Delivery to Brain Tumors
Feng, Y., Cao, Y., Kavallaris, M., Janjua, T. I., & Popat, A. (2026) · Advanced Materials · doi:10.1002/adma.74760
Proceedings of ISAM 2025 Workshop Entitled “Intranasal Delivery of Aerosolized Vaccines”
Laube, B. L., & Suman, J. (2026) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1177/19412711261470615
Sharma, M., & Arora, K. (2026) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2026v18i5.9087
Gomes, V. H., Stocco, A. V., de Resende, A. V., Farsette, A. B. N., da Silva, L. N., & Balthazar, D. D. A. (2026) · Journal of Medical Primatology · doi:10.1111/jmp.70115
Özbay, B. (2025) · Qucosa (Saxon State and University Library Dresden)
Thorat, V. P., & Paliwal, P. P. (2026) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-026-11086-9
Gaber, D. M. (2026) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2026.2744568
Saeed, O., Nounou, M. V., Saeed, A., Rochwerg, B. N., Abdelaziz, A., Weinhouse, G. L., Shim, S. R., & Elhadi, M. (2026) · Critical Care and Resuscitation · doi:10.1016/j.ccrj.2026.100227
Interrogating the role of splicing factors in Huntington’s Disease
Kooner, G. S. (2015) · Figshare
Metadata
- Authors
- Pires, A., Fortuna, A., Alves, G., & Falcão, A.
- Affiliations
- University of Coimbra (PT)
- University of Beira Interior (PT)
- Venue
- Journal of Pharmacy & Pharmaceutical Sciences
- Publisher
- Frontiers Media SA
- Published
- 2009-10-12
- Volume
- 12
- Issue
- 3
- Pages
- 288
- ISSN
- 1482-1826 (ISSN-L)
- OpenAlex
- W2106536537
- Cited by
- 641
- References
- 175
- Citations by year
- 2026: 31 · 2025: 49 · 2024: 44 · 2023: 45 · 2022: 67 · 2021: 65 · 2020: 48 · 2019: 41 · 2018: 35 · 2017: 42 · 2016: 35 · 2015: 29 · 2014: 32 · 2013: 25 · 2012: 23
- FWCI
- 1.76
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Journal of Pharmacy & Pharmaceutical Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion)
- Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) (submittedVersion, cc-by-sa)
- Funders
- Fundação para a Ciência e a Tecnologia (SFRH/BD/45145/2008)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Health Sciences › Medicine › Otorhinolaryngology › Sinusitis and nasal conditions
- Keywords
- intranasal drug delivery, nasal mucosa, transmucosal drug absorption, brain drug delivery, topical drug delivery, systemic drug delivery
- MeSH terms
- Absorption, Administration, Intranasal, Animals, Biological Availability, Humans, Nasal Cavity, Nasal Mucosa, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.